Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection

Clinical Nephrology

Volumn 52, Issue 6, 1999, Pages 357-362

  Ikeda, K ^a,b   Ida, O ^a   Kimoto, K ^a   Takatorige, T ^a   Nakanishi, N ^a   Tatara, K ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Escheria coli O157:H7 infection; Fosfomycin treatment; Hemolytic uremic syndrome(HUS)

Indexed keywords

AMINOGLYCOSIDE; CEPHALOSPORIN; FOSFOMYCIN; PENICILLIN G; QUINOLONE; TETRACYCLINE;

ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL TRIAL; DRUG EFFICACY; ESCHERICHIA COLI O157; FEMALE; FEVER; HEMOLYTIC UREMIC SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; RISK; SCHOOL CHILD;

ANTI-BACTERIAL AGENTS; CHILD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FOSFOMYCIN; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 0032753465     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Boyce TG, Swerdlow DL, Griffin PM 1995 Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 333: 364-368
2. Butler T, Islam MR, Azad MAK, Jones PK 1987 Risk factors for development of hemolytic uremic syndrome during shigellosis. J Pediatr 110: 894-897
3. Carter AO, Borczyk AA, Carlson JAK, Harvey B, Hockin JC, Karmali MA, Krishnan C, Korn DA, Lior H 1987 A severe outbreak of Escherichia coli O157:H7-associated hemorrhagic colitis in a nursing home. N Engl J Med 317: 1496-500
4. Cimolai N, Carter JE, Morrison BJ, Anderson JD 1990 Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome. J Pediatr 116: 589-592
5. Griffin PM, Ostroff SM, Tauxe RV, Greene KD, Wells JG, Lewis JH, Blake PA 1988 Illnesses associated with Escherichia coli O157:H7 infections: A broad clinical spectrum. Ann Intern Med 109: 705-712
6. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H 1985 The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151: 775-782
7. Nihon Syouni Jinzobyo Gakkai (The Japanese Society of Pediatric Nephrology) 1997 Cyokansyukettusei Daicyokin Kansensyo nitomonau Yoketusei Nyodokusyo Syokogun no Sindan Chiryo Gaidorain (Guidelines of Diagnosis and Therapy for Hemolytic Uremic Syndrome with Entero Hemorrhagic Escherichia coli infection). Jpn J Pediatr 101: 745-746
8. Ostroff SM, Kobayashi JM, Lewis JH 1989 Infections with Escherichia coli O157:H7 in Washington State. JAMA 262: 355-359
9. Pavia AT, Nichols CR, Green DP, Tauxe RV, Mottice S, Greene KD, Wells JG, Siegler RL, Brewer ED, Hannon D, Blake PA 1990 Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: Clinical and epidemiologic observations. J Pediatr 116: 544-51
10. Proulx F, Turgeon JP, Delage G, Lafleur L, Chicoine L 1992 Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. J Pediatr 121: 299-303
11. Railey LW, Remis RS, Helgerson SD, McGee HB, Wells JG, Davis BR, Hebert RJ, Olcott ES, Johnson LM, Hargrett NT, Blake PA, Cohen ML 1983 Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308: 681-685
12. Robson WLM, Leung AKC, Kaplan BS 1993 Hemolytic-uremic syndrome. Curr Probl Pediatr 23: 16-33
13. Rowe PC, Orrbine E, Lior H, Wells GA, McLaine PN 1993 A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. Epidemiol Infect 110: 1-7
14. Sakai City Hospital 1996 Byogensei Daicyokin O-157 Kansen Chiryo Shishin (Guidelines for Treatment of Patients with E. coli O157 infection). Available from: URL:http://www.med.osaka-u.ac.jp/~sakai-hp/trea t.html
15. Sakai City Medical Association 1996 Sakaishi niokeru O157 gakudosyudangerisyo no keikatojittai (Progress and actual situation on the Mass Outbreak of Diarrhea by School Children of Sakai City). Sakai City Medical Association, Sakai City July 1996
16. Task Force on the Mass Outbreak of Diarrhea in School Children of Sakai City 1997 Report on the Outbreak of E. coli O157 Infection in Sakai City. Sakai City Office, Sakai City, pp 4-7, 2747
17. Yoh M, Frimpong EK, Honda T 1997 Effect of antimicrobial agents, especially fosfomycin, on the production and release of Verotoxin by enterohaemorrhagic Escherichia coli O157:H7. FEMS Immunol Med Microbiol 19: 57-64